These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39325736)

  • 1. Influence of social determinants of health on quality of life in patients with multimorbidity and polypharmacy.
    Ruiz-Baena JM; Moreno-Juste A; Poblador-Plou B; Castillo-Jimena M; Calderón-Larrañaga A; Lozano-Hernández C; Gimeno-Miguel A; Gimeno-Feliú LA;
    PLoS One; 2024; 19(9):e0297702. PubMed ID: 39325736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social support, social context and nonadherence to treatment in young senior patients with multimorbidity and polypharmacy followed-up in primary care. MULTIPAP Study.
    Lozano-Hernández CM; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; Barrio-Cortes J; Gimeno-Feliu LA; Poblador-Plou B; Cura-González ID;
    PLoS One; 2020; 15(6):e0235148. PubMed ID: 32579616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
    Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
    Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study).
    Verdoorn S; Kwint HF; Blom JW; Gussekloo J; Bouvy ML
    PLoS Med; 2019 May; 16(5):e1002798. PubMed ID: 31067214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.
    Del Cura-González I; López-Rodríguez JA; Leiva-Fernández F; Gimeno-Feliu LA; Pico-Soler V; Bujalance-Zafra MJ; Domínguez-Santaella M; Polentinos-Castro E; Poblador-Plou B; Ara-Bardají P; Aza-Pascual-Salcedo M; Rogero-Blanco M; Castillo-Jiménez M; Lozano-Hernández C; Gimeno-Miguel A; González-Rubio F; Medina-García R; González-Hevilla A; Gil-Conesa M; Martín-Fernández J; Valderas JM; Marengoni A; Muth C; Prados-Torres JD; Prados-Torres A;
    Trials; 2022 Jun; 23(1):479. PubMed ID: 35681224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic inequalities in health-related quality of life among older adults in England: secondary analysis of a national cross-sectional survey.
    Watkinson RE; Sutton M; Turner AJ
    Lancet Public Health; 2021 Mar; 6(3):e145-e154. PubMed ID: 33516278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.
    Lopez-Rodriguez JA; Rogero-Blanco E; Aza-Pascual-Salcedo M; Lopez-Verde F; Pico-Soler V; Leiva-Fernandez F; Prados-Torres JD; Prados-Torres A; Cura-González I;
    PLoS One; 2020; 15(8):e0237186. PubMed ID: 32785232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment burden and health-related quality of life of patients with multimorbidity: a cross-sectional study.
    Gebreyohannes EA; Gebresillassie BM; Mulugeta F; Dessu E; Abebe TB
    Qual Life Res; 2023 Nov; 32(11):3269-3277. PubMed ID: 37405663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of health-related quality by multimorbidity groups in primary health care.
    Millá-Perseguer M; Guadalajara-Olmeda N; Vivas-Consuelo D; Usó-Talamantes R
    Health Qual Life Outcomes; 2019 Jan; 17(1):8. PubMed ID: 30634992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inequalities in health-related quality of life according to age, gender, educational level, social class, body mass index and chronic diseases using the Spanish value set for Euroquol 5D-5L questionnaire.
    Arrospide A; Machón M; Ramos-Goñi JM; Ibarrondo O; Mar J
    Health Qual Life Outcomes; 2019 Apr; 17(1):69. PubMed ID: 30999899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy and Health-Related Quality of Life/Psychological Distress Among Patients With Chronic Disease.
    Van Wilder L; Devleesschauwer B; Clays E; Pype P; Vandepitte S; De Smedt D
    Prev Chronic Dis; 2022 Aug; 19():E50. PubMed ID: 35980834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project).
    Prados-Torres A; Del Cura-González I; Prados-Torres D; López-Rodríguez JA; Leiva-Fernández F; Calderón-Larrañaga A; López-Verde F; Gimeno-Feliu LA; Escortell-Mayor E; Pico-Soler V; Sanz-Cuesta T; Bujalance-Zafra MJ; Morey-Montalvo M; Boxó-Cifuentes JR; Poblador-Plou B; Fernández-Arquero JM; González-Rubio F; Ramiro-González MD; Coscollar-Santaliestra C; Martín-Fernández J; Barnestein-Fonseca MP; Valderas-Martínez JM; Marengoni A; Muth C;
    Implement Sci; 2017 Apr; 12(1):54. PubMed ID: 28449721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between health-related quality of life, perceived family support and unmet health needs in adult patients with multimorbidity attending primary care in Portugal: a multicentre cross-sectional study.
    Prazeres F; Santiago L
    Health Qual Life Outcomes; 2016 Nov; 14(1):156. PubMed ID: 27835995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator.
    Assari S; Wisseh C; Bazargan M
    Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31226752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and internal validation of prognostic models to predict negative health outcomes in older patients with multimorbidity and polypharmacy in general practice.
    Müller BS; Uhlmann L; Ihle P; Stock C; von Buedingen F; Beyer M; Gerlach FM; Perera R; Valderas JM; Glasziou P; van den Akker M; Muth C
    BMJ Open; 2020 Oct; 10(10):e039747. PubMed ID: 33093036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimorbidity, health Literacy, and quality of life among older adults in an urban slum in India: a community-based cross-sectional study.
    Yogesh M; Makwana N; Trivedi N; Damor N
    BMC Public Health; 2024 Jul; 24(1):1833. PubMed ID: 38982428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in social support perceived by polymedicated older adults with multimorbidity. MULTIPAP study.
    Lozano-Hernández CM; López-Rodríguez JA; Rico-Blázquez M; Calderón-Larrañaga A; Leiva-Fernández F; Prados-Torres A; Del Cura-González I;
    PLoS One; 2022; 17(7):e0268218. PubMed ID: 35895702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Adherence Patterns Across Multiple Medications and Their Association With Health Outcomes in Older Community-Dwelling Adults With Multimorbidity.
    Walsh CA; Bennett KE; Wallace E; Cahir C
    Value Health; 2020 Aug; 23(8):1063-1071. PubMed ID: 32828219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial factors associated with medication burden among community-dwelling older people with multimorbidity.
    Yang C; Zhu S; Hui Z; Mo Y
    BMC Geriatr; 2023 Nov; 23(1):741. PubMed ID: 37964196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication-related factors associated with health-related quality of life in patients older than 65 years with polypharmacy.
    Montiel-Luque A; Núñez-Montenegro AJ; Martín-Aurioles E; Canca-Sánchez JC; Toro-Toro MC; González-Correa JA;
    PLoS One; 2017; 12(2):e0171320. PubMed ID: 28166266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.